Classification
Product TypeIngredient
Product FormPowder
Industry PositionBotanical ingredient (food and dietary supplement use)
Market
In the United States, amla (Phyllanthus emblica) powder is primarily positioned as an imported botanical ingredient used in dietary supplement and natural-products channels, with market access and continuity heavily shaped by FDA import oversight (FSVP/prior notice), labeling/cGMP expectations, and quality-risk controls for contaminants and adulteration.
Market RoleImport-dependent consumer and processing market (net importer)
Domestic RoleDownstream formulation and retail market for botanical powders (food and dietary supplement uses) under FDA oversight
Market Growth
Specification
Compositional Metrics- Buyer specifications in US channels commonly emphasize identity testing (botanical authentication) and contaminant controls (e.g., heavy metals and microbiological quality) aligned to dietary supplement cGMP expectations and compendial methods where used.
Supply Chain
Value Chain- Overseas drying/milling -> importer of record -> FDA import admissibility screening (FSVP/prior notice) -> US warehousing -> downstream repacking/blending or contract manufacturing -> retail/online distribution
Temperature- Typically shipped and stored as an ambient-stable dry powder; moisture control and clean, sealed packaging are key to preventing caking and microbial growth risk.
Shelf Life- Shelf-life performance is primarily driven by moisture ingress control, odor absorption prevention, and lot-level stability/COA management in downstream storage.
Freight IntensityMedium
Transport ModeSea
Risks
Food Safety / Regulatory HighUS entry can be delayed, detained, or refused if amla powder shipments (or downstream finished products using the ingredient) trigger FDA concerns over contaminants (notably heavy metals in botanical products), adulteration, or misbranding; repeated issues can escalate to import-alert style scrutiny and significant commercial disruption.Implement robust supplier qualification under FSVP, require COAs with validated methods, perform independent third-party lab testing for heavy metals and microbiology, and maintain cGMP-aligned identity/specification programs for each lot.
Logistics MediumOcean freight volatility, port congestion, and extended customs/FDA clearance timelines can disrupt replenishment for bulk botanical powders, increasing stockout and working-capital risk for US blenders and supplement manufacturers.Use safety-stock policies tied to lead-time variability, diversify qualified suppliers/origins where feasible, and pre-stage compliance documentation to reduce avoidable clearance delays.
Documentation Gap MediumInconsistent product description (intended use, composition, processing level) and incomplete specification/identity documentation can trigger classification disputes, extended holds, or downstream QA rejection in US channels.Standardize product specification sheets, botanical identity documentation, and consistent declared use/labeling position (food vs dietary supplement) across contracts, entries, and customer documents.
Labor & Social- Heightened consumer and regulator sensitivity to truthful marketing and safety of imported herbal/Ayurvedic-style botanical products in US channels; social risk escalates when contamination or adulteration incidents occur.
Standards- NSF/ANSI 173 (dietary supplements) (buyer-driven)
- USP Verified Mark / USP compendial testing approaches (buyer-driven)
FAQ
What US compliance frameworks most commonly affect importing amla powder for supplement or food use?For FDA-regulated imports, US importers commonly need to comply with FDA entry requirements (including Prior Notice for foods) and, for many food ingredients, the Foreign Supplier Verification Program (FSVP). If the product is marketed as a dietary supplement ingredient, manufacturing and quality systems are commonly expected to align with FDA dietary supplement cGMP requirements.
What is the biggest trade-stopping risk for amla powder shipments into the US?The most disruptive risk is FDA detention or refusal triggered by safety or compliance concerns such as contaminants (including heavy metals in botanical products), adulteration, or misbranding. Strong supplier verification, lot testing, and documentation readiness reduce the chance and impact of holds.
How should US buyers think about product classification and tariffs for amla powder?Duty treatment depends on the exact HTSUS classification, which can vary based on how the powder is described and presented. Buyers typically verify the current HTSUS heading and duty rate with the USITC schedule and align product descriptions consistently across contracts and entry documents.
Sources
U.S. Food and Drug Administration (FDA) — Food Safety Modernization Act (FSMA) — Foreign Supplier Verification Programs (FSVP) for food importers (21 CFR 1 Subpart L)
U.S. Food and Drug Administration (FDA) — Dietary Supplement Current Good Manufacturing Practice (cGMP) requirements (21 CFR Part 111)
U.S. Food and Drug Administration (FDA) — Prior Notice requirements for imported foods
U.S. Customs and Border Protection (CBP) — Importing into the United States — CBP entry and clearance guidance
United States International Trade Commission (USITC) — Harmonized Tariff Schedule of the United States (HTSUS)
USDA Animal and Plant Health Inspection Service (USDA APHIS) — Plant product import guidance and agricultural import requirements (commodity-specific)
U.S. Pharmacopeia (USP) — USP dietary supplement quality standards and contaminant testing references (including elemental contaminants guidance)
NSF — NSF/ANSI 173 — Dietary Supplements (certification standard used in US buyer programs)